StockWatch
·
Pharmaceuticals
Board Meeting4 Aug 2026, 05:00 pm

Abbott India Board Meeting on Aug 12 to Approve Unaudited Results

AI Summary

Abbott India Ltd has announced that its Board of Directors will convene on August 12, 2026. The primary agenda item for this meeting is to consider and approve the company's unaudited financial results for the quarter ended June 30, 2026. In line with SEBI regulations, the trading window for the company's shares will remain closed from July 1, 2026, to August 14, 2026, inclusive, to prevent insider trading.

Key Highlights

  • Board meeting scheduled for August 12, 2026.
  • Purpose: Approve unaudited financial results for Q1 FY27.
  • Trading window closed from July 1 to August 14, 2026.
  • Measures in place to prevent insider trading.